AI Biosciences

AI Biosciences is a private early-stage diagnostics company based in College Station, Texas focused on rapid, low-cost, point-of-care molecular testing. The company develops automated sample preparation and nucleic acid testing systems designed for low-resource, field, and microgravity settings, with an emphasis on delivering laboratory-quality molecular diagnostics in under 25 minutes. Its best-known platform is the μTitan sample processing instrument, a microgravity-compatible automated nucleic acid extraction system. AI Biosciences has also published work on low-cost PCR, RT-PCR, RT-RPA, and mobile diagnostic concepts for applications including SARS-CoV-2 and Zika virus testing. Overall, the company appears to be a platform-oriented molecular diagnostics developer rather than a therapeutics company.